Cladrim

Cladrim

  • Cladrim belong to Class of drugs - Chlorinated purine nucleoside analogue

  • Cladribine is indicated for the treatment of Hairy Cell Leukemia

  • The recommended dose and schedule of Cladribine Injection for active Hairy Cell Leukemia is a single course given by continuous infusion for 7 consecutive days at a dose of 0.09 mg/kg/day. It is advised to proceed carefully in patients with known or suspected renal insufficiency or severe bone marrow impairment of any etiology.

  • Cladrim is available as 10mg Injection for the use only of a Registered Medical Practitioner or a Hospital or a Laboratory